President Donald Trump said he may veto legislation extending Affordable Care Act subsidies, as Senate lawmakers debate whether to advance or modify a House-passed bill reviving the Biden-era tax credits.
By yourNEWS Media Newsroom
President Donald Trump said he may veto legislation extending Affordable Care Act subsidies if the measure reaches his desk, injecting new uncertainty into a bipartisan effort to revive the tax credits after their expiration at the end of last year.
Speaking to reporters aboard Air Force One on Jan. 11 while traveling to Maryland, Trump responded “I might” when asked whether he would reject the bill should it clear the Senate. His comments followed House passage of the measure earlier this month, despite opposition from Speaker Mike Johnson, who had previously blocked debate on renewing the subsidies commonly referred to as Obamacare credits.
On Jan. 7, the House voted 221–205 to advance a Democrat-led discharge petition forcing consideration of the bill, with nine Republicans joining Democrats. The chamber then approved the legislation in a final 230–196 vote on Jan. 8, this time with 17 Republicans in support.
The bill would reinstate enhanced ACA premium tax credits created under the American Rescue Plan Act of 2021 and later extended through the Inflation Reduction Act of 2022. Those subsidies expired at the end of 2025, setting off a renewed political fight over the future of the program.
Extension of the credits played a central role in the most recent federal government shutdown, which stretched from October into November and became the longest in U.S. history. After several Senate Democrats voted to reopen the government without securing a subsidy extension, House Democrats moved ahead with their own effort to revive the credits.
Republicans remain divided. Many GOP lawmakers argue the subsidies should lapse permanently, while a smaller bloc supports a temporary extension to avoid coverage disruptions.
“Obamacare has been a failure that’s enriched insurance providers at the expense of patients,” Sen. Ted Cruz wrote in a Jan. 11 post on X. “There are many reforms we can and should make to our healthcare system. Extending the ACA’s subsidies isn’t one of them, and doing so only further perpetuates Obamacare’s damage to American consumers.”
Rep. Mike Carey, one of the Republicans who voted for the House bill, argued that allowing the subsidies to expire abruptly would leave thousands without coverage. In a statement following the vote, Carey said close to 45,000 residents in his Ohio district rely on the plans and should not lose access while lawmakers continue debating broader healthcare reforms, according to his remarks shared on X.
The Senate has not yet voted on the House-passed measure. While Democrats may struggle to secure enough Republican votes to pass the bill in its current form, a bipartisan group of senators is discussing a narrower compromise.
That proposal would extend the enhanced tax credits for two years but add new limits, including a minimum monthly premium, stricter income caps, and an option in the second year for subsidies to be delivered through pre-funded health savings accounts. Under the framework, premium assistance would phase out entirely once household income reaches $200,000.
Trump has repeatedly argued for moving away from the ACA in favor of expanded use of health savings accounts, which he says give individuals greater control over their healthcare spending. His tax and spending package, the One Big Beautiful Bill Act, expanded eligibility for HSAs, making an additional 7.3 million Americans eligible to participate.
HSAs allow individuals and employers to contribute pre-tax funds for medical expenses when paired with high-deductible health plans. The funds can be used for qualified healthcare costs at any time and, after age 65, for non-medical expenses subject to standard income taxes.
As Senate negotiations continue, Trump’s veto threat adds another hurdle for lawmakers attempting to chart a path forward on the future of Obamacare’s enhanced subsidies.
Original article
Comments